Bexitrol F Inhalation Capsule 50 mcg+100 mcg is a combination inhalation therapy containing Salmeterol, a long-acting beta-2 adrenergic agonist, and Fluticasone Propionate, a well-established inhaled corticosteroid. This formulation is intended for the regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), particularly in patients with mild to moderate disease who require both bronchodilation and control of airway inflammation.

The inhalation capsules are designed to be used with a compatible dry powder inhaler device. This delivery system ensures that the medication is deposited directly into the lungs, providing targeted therapeutic action with minimal systemic exposure. Bexitrol F Inhalation Capsule is not meant for the relief of acute bronchospasm and should be used consistently as prescribed for long-term disease control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Long-acting beta-2 agonist (LABA) + Inhaled corticosteroid (ICS)

Indications

Bexitrol F Inhalation Capsule 50 mcg+100 mcg is indicated for:

• Maintenance treatment of bronchial asthma in patients not adequately controlled with low-dose inhaled corticosteroids alone

• Long-term control of asthma symptoms such as wheezing, cough, chest tightness, and shortness of breath

• Maintenance therapy of chronic obstructive pulmonary disease (COPD) where combination therapy is appropriate

This strength is particularly suitable for patients at an early stage of combination inhaler therapy.

Pharmacology

Salmeterol is a selective long-acting beta-2 adrenergic receptor agonist. It produces prolonged relaxation of bronchial smooth muscles, resulting in sustained bronchodilation for up to 12 hours. This helps prevent bronchospasm and improves airflow during both day and night.

Fluticasone Propionate is a potent inhaled corticosteroid with strong anti-inflammatory properties. It suppresses airway inflammation by inhibiting the release of inflammatory mediators, reducing mucosal edema, and decreasing airway hyper-responsiveness. Regular use helps prevent asthma exacerbations and improves lung function.

The combined action of these two agents provides better symptom control and disease stability than either component alone.

Dosage and Administration

Bexitrol F Inhalation Capsule is for inhalation use only.

• The usual recommended dose is one inhalation capsule twice daily or as directed by a physician

• Capsules must not be swallowed and should only be used with an appropriate dry powder inhaler device

• Patients should rinse the mouth with water after inhalation and spit it out to reduce the risk of oral fungal infections

Correct inhaler technique is essential to achieve maximum therapeutic benefit.

Contraindications

Bexitrol F Inhalation Capsule is contraindicated in:

• Patients with known hypersensitivity to Salmeterol, Fluticasone Propionate, or any excipient

• Acute asthma attacks or status asthmaticus requiring rapid-acting bronchodilators

Side Effects

Possible side effects include:

• Throat irritation or hoarseness

• Headache

• Cough

• Oral candidiasis

• Tremor or palpitations (uncommon)

Most adverse effects are mild and reversible with proper use.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not intended for immediate relief of acute bronchospasm

• Use with caution in patients with cardiovascular disease, diabetes mellitus, or thyroid disorders

• Avoid abrupt discontinuation without medical advice

• Long-term use requires regular medical monitoring

Pregnancy and Lactation

Bexitrol F Inhalation Capsule should be used during pregnancy and lactation only if the potential benefit justifies the potential risk and under medical supervision.

Storage Conditions

Store below 30°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Conclusion

Bexitrol F Inhalation Capsule 50 mcg+100 mcg is an effective maintenance therapy for patients with asthma or COPD who require reliable bronchodilation along with anti-inflammatory control. Regular use helps maintain symptom stability, reduces exacerbations, and supports improved respiratory function and quality of life.